BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 9300938)

  • 1. A novel biomarker of interleukin 6 activity and clinical and cognitive outcomes in depression.
    Foley ÉM; Slaney C; Donnelly NA; Kaser M; Ziegler L; Khandaker GM
    Psychoneuroendocrinology; 2024 Jun; 164():107008. PubMed ID: 38442505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychologic and biologic factors associated with fatigue in patients with persistent radiculopathy.
    Starkweather A
    Pain Manag Nurs; 2013 Mar; 14(1):41-9. PubMed ID: 23452526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma soluble IL-6 receptor concentration in rheumatoid arthritis: associations with the rs8192284 IL6R polymorphism and with disease activity.
    Rodríguez-Rodríguez L; Lamas JR; Varadé J; López-Romero P; Tornero-Esteban P; Abasolo L; de la Concha EG; Jover JA; Urcelay E; Fernández-Gutiérrez B
    Rheumatol Int; 2011 Mar; 31(3):409-13. PubMed ID: 20661738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the role of sIL-2R measurements in rheumatoid arthritis and cancers.
    Witkowska AM
    Mediators Inflamm; 2005 Aug; 2005(3):121-30. PubMed ID: 16106097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low circulating soluble interleukin 2 receptor level predicts rapid response in patients with refractory rheumatoid arthritis treated with infliximab.
    Kuuliala A; Nissinen R; Kautiainen H; Repo H; Leirisalo-Repo M
    Ann Rheum Dis; 2006 Jan; 65(1):26-9. PubMed ID: 15941839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 and the network of several cytokines in multiple myeloma: an overview of clinical and experimental data.
    Lauta VM
    Cytokine; 2001 Nov; 16(3):79-86. PubMed ID: 11741345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor.
    Peake NJ; Khawaja K; Myers A; Nowell MA; Jones SA; Rowan AD; Cawston TE; Foster HE
    Rheumatology (Oxford); 2006 Dec; 45(12):1485-9. PubMed ID: 16690760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies.
    Usón J; Balsa A; Pascual-Salcedo D; Cabezas JA; Gonzalez-Tarrio JM; Martín-Mola E; Fontan G
    J Rheumatol; 1997 Nov; 24(11):2069-75. PubMed ID: 9375862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-2 receptor levels in sera of patients with rheumatoid arthritis treated with sulfasalazine, parenteral gold, or placebo.
    Merkel PA; Dooley MA; Dawson DV; Pisetsky DS; Polisson RP
    J Rheumatol; 1996 Nov; 23(11):1856-61. PubMed ID: 8923356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of corticosteroid pulse therapy on the serum levels of soluble interleukin 2 receptor, interleukin 6 and interleukin 8 in patients with rheumatoid arthritis.
    van den Brink HR; van Wijk MJ; Geertzen RG; Bijlsma JW
    J Rheumatol; 1994 Mar; 21(3):430-4. PubMed ID: 7911833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of soluble interleukin-2-receptor and interleukin-6 with class-specific rheumatoid factors during low-dose methotrexate treatment in rheumatoid arthritis.
    Spadaro A; Taccari E; Riccieri V; Sensi F; Sili Scavalli A; Zoppini A
    Rev Rhum Engl Ed; 1997 Feb; 64(2):89-94. PubMed ID: 9085442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6, soluble interleukin-2-receptor and soluble interleukin-6-receptor in sera of patients with rheumatoid arthritis: influences of disease activity and drug therapy.
    Franke S; Herrmann D; Hein G; Müller A; Stein G
    Eur J Med Res; 1997 Sep; 2(9):401-6. PubMed ID: 9300938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antirheumatic agents on cytokines.
    Barrera P; Boerbooms AM; van de Putte LB; van der Meer JW
    Semin Arthritis Rheum; 1996 Feb; 25(4):234-53. PubMed ID: 8834013
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.